Cargando…

5-alpha reductase inhibitors (5-ARi) with or without alpha-blockers (α-B) for Benign Prostatic Hyperplasia do NOT lower the risk of incident Bladder Cancer: United States insurance claims data

BACKGROUND: Chemoprotective effect of 5-alpha reductase inhibitors (5-ARi) on bladder cancer (BCa) risk in men with Benign Prostatic Hyperplasia (BPH) has been explored with conflicting results. We sought to examine the effect of 5-ARi on new BCa diagnoses in a large US database. METHODS: Men ≥ 50 y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Del Giudice, Francesco, Belladelli, Federico, Glover, Frank, Basran, Satvir, Li, Shufeng, Mulloy, Evan, Pradere, Benjamin, Soria, Francesco, Krajewski, Wojciech, Nair, Rajesh, Muncey, Wade, Seranio, Nicolas, Eisenberg, Michael L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582125/ https://www.ncbi.nlm.nih.gov/pubmed/37548746 http://dx.doi.org/10.1007/s00345-023-04551-4

Ejemplares similares

Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis
por: Belladelli, Federico, et al.
Publicado: (2023)

Male Fertility and Physical Exercise
por: Belladelli, Federico, et al.
Publicado: (2023)

The Association between Monthly, Yearly, and Lifetime Cannabis Use, and Semen Parameters in Asian-American Men
por: Belladelli, Federico, et al.
Publicado: (2023)

The association between organophosphate insecticides and blood pressure dysregulation: NHANES 2013–2014
por: Glover, Frank, et al.
Publicado: (2022)

The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
por: Ayodele, Olulade, et al.
Publicado: (2021)

The association between caffeine intake and testosterone: NHANES 2013–2014
por: Glover, Frank E., et al.
Publicado: (2022)

Persistence and adherence to dutasteride/tamsulosin fixed-dose versus free-combination alpha blocker/5ARI therapy in patients with benign prostate hyperplasia in Germany
por: Eisen, Christoph, et al.
Publicado: (2020)

Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
por: Kim, Jae Heon, et al.
Publicado: (2018)

Risk of Depression after 5 Alpha Reductase Inhibitor Medication: Meta-Analysis
por: Kim, Jae Heon, et al.
Publicado: (2020)

Alpha–blocker and apoptosis
por: Elterman, Dean S., et al.
Publicado: (2013)

Risk of Hip Fractures in Men with Alpha-Blockers: A Nationwide Study Base on Claim Registry
por: Seo, Gi-Hyeon, et al.
Publicado: (2015)

5-alpha-reductase and the development of the human prostate
por: Radmayr, C., et al.
Publicado: (2008)

α-Blocker Monotherapy and α-Blocker Plus 5-Alpha-Reductase Inhibitor Combination Treatment in Benign Prostatic Hyperplasia; 10 Years' Long-Term Results
por: Shin, Teak Jun, et al.
Publicado: (2012)

Diagnoses and medications associated with delayed ejaculation
por: Mulloy, Evan, et al.
Publicado: (2023)

Sheep (Ovis aries) T cell receptor alpha (TRA) and delta (TRD) genes and genomic organization of the TRA/TRD locus
por: Piccinni, Barbara, et al.
Publicado: (2015)

Diagnosis of prostate cancer with magnetic resonance imaging in men treated with 5-alpha-reductase inhibitors
por: Falagario, Ugo G., et al.
Publicado: (2023)

Analysis of Prescriptions of Alpha-Blockers and Phosphodiesterase 5 Inhibitors from the Urology Department and Other Departments
por: Kang, Dong Hyuk, et al.
Publicado: (2011)

The Role of Alpha Blockers in Children with Dysfunctional Voiding
por: Austin, Paul F.
Publicado: (2009)

Effect of alpha1-blockers on stentless ureteroscopic lithotripsy
por: Zhu, Jianguo, et al.
Publicado: (2016)

Predictive factors for alpha blocker use after transurethral prostatectomy: Can preoperative urodynamic outcome predict alpha blocker medication after surgery?
por: Kim, Sung Jin, et al.
Publicado: (2022)

Role of 5 alpha-reductase inhibitors in the management of prostate cancer
por: Hudak, Steven J, et al.
Publicado: (2006)

Prostate Cancer Mortality and Use of 5-Alpha Reductase Inhibitors
por: Foldes, Cara A., et al.
Publicado: (2020)

5-alpha reductase inhibitors use in prostatic disease and beyond
por: Chislett, Bodie, et al.
Publicado: (2023)

The heavy quarkonium spectrum at order $m\alpha_{s}^{5}\ln\alpha_{s}$
por: Brambilla, Nora, et al.
Publicado: (1999)

The Anticholinesterase Phenserine and Its Enantiomer Posiphen as 5′Untranslated-Region-Directed Translation Blockers of the Parkinson's Alpha Synuclein Expression
por: Mikkilineni, Sohan, et al.
Publicado: (2012)

Association of daily step count and serum testosterone among men in the United States
por: Del Giudice, Francesco, et al.
Publicado: (2021)

5-Alpha-Reductase 2 Deficiency in a Woman with Primary Amenorrhea
por: Maleki, Nasrollah, et al.
Publicado: (2013)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
por: Kim, Eric H., et al.
Publicado: (2018)

Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
por: Escamilla-Cruz, Mariana, et al.
Publicado: (2023)

The association of impaired semen quality and pregnancy rates in assisted reproduction technology cycles: Systematic review and meta‐analysis
por: Del Giudice, Francesco, et al.
Publicado: (2022)

Lowering $\alpha_{s}$ by flipping SU(5)
por: Ellis, John R., et al.
Publicado: (1995)

The skin tissue is adversely affected by TNF-alpha blockers in patients with chronic inflammatory arthritis: a 5-year prospective analysis
por: Machado, Natalia P., et al.
Publicado: (2013)

Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis
por: Hollingsworth, John M, et al.
Publicado: (2016)

Differential expression of 5-alpha reductase isozymes in the prostate and its clinical implications
por: Wang, Kai, et al.
Publicado: (2014)

Clinical presentations and molecular characterization of Indonesian children with 5 alpha-reductase deficiency
por: Marzuki, Nanis S, et al.
Publicado: (2013)

Integrative and Analytical Review of the 5-Alpha-Reductase Type 2 Deficiency Worldwide
por: Batista, Rafael Loch, et al.
Publicado: (2020)

ALPHA (AD-5) Status Report for 2014
por: Hangst, JS
Publicado: (2015)

Prospective Factor Analysis of Alpha Blocker Monotherapy Failure in Benign Prostatic Hyperplasia
por: Hong, Kyoung Pyo, et al.
Publicado: (2010)

Comparison of Alpha Blockers in Treatment of Premature Ejaculation: A Pilot Clinical Trial
por: Akin, Yigit, et al.
Publicado: (2013)

Complications of cataract surgery in patients with BPH treated with alpha 1A-blockers
por: Jan Teper, Slawomir, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_k58p73smcsqb6triprp0msf0ni